Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular-Growth
Equity
Sectoral-Pharma
₹-0.22% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Other Info
Fund Overview
Rating
3
Minimum Investment
₹100
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹192 Cr
Created on
1 Oct 2020
Fund Ranking
#13
/ 19 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
6 Month
13.3%
1 Year
15.0%
3 Year (CAGR)
18.0%
All Time (CAGR)
15.1%
Category Return
6 Month
10.9%
1 Year
8.5%
3 Year (CAGR)
18.8%
All Time (CAGR)
16.8%
Asset Allocation
Equity
99.9%
Debt
0.1%
Other
-0.0%
Top 5 Holdings
Top 5 Sectors
Apollo Hospitals Enterprise
5.25%
Aurobindo Pharma
2.77%
Cipla
4.34%
Dr. Reddy's Laboratories
3.95%
Ipca Laboratories
1.72%
Fund Information
Expense Ratio
1.10%
Exit Load
No Exit Load
Lock-In Period
No Lock-In
Managed By
Bhavesh Jain
Oct 2021 - Present
Amit Vora
Feb 2021 - Present
Manasi Jalgaonkar
April 2026 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
0.95
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
12.53
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
1.68
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.